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Introduction 
Organic phosphorus compounds are of 
considerable interest and importance by vir-
ture of their widespread use as insecticides; 
their effectiveness in the treatment of my-
asthenia gravis, glaucoma, and abdominal 
distention; and their potential application as 
war gases. These compounds owe their 
pharmacologic effect primarily, if not entire-
ly, to their ability to inhibit the enzyme 
cholinesterase with a resultant overstimula-
tion of the parasympathetic nervous system 
by the acetylcholine which accumulates. 
Atropine has been the drug of choice for the 
treatment of organophosphorus poisoning. 
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This therapy produces relief of symptoms 
based on blocking the action of excess acetyl-
choline. 
More recently, a number of specific anti-
dotes have been developed which act to repair 
the basic biochemical lesion in organic phos-
phorus poisoning by freeing the cholinester-
ase from its combination with the inhibitor. 
In the present paper, some of the pertinent 
background material relative to' organic phos-
phorus poisoning will be reviewed, and the 
properties and usage of these specific anti-
dotes will be discussed in some detail. Em-
phasis will be given to those aspects of 
symptomatology and treatment which might 
be of most value to the physician faced with 
a presumptive case of poisoning. 
Nature and Physiologic Function 
of Cholinesterase 
There are 2 general types of cholinesterase 
present in the animal organism.9 These are: 
( 1) the true, specific enzyme, acetylcholin-
esterase, which has an almost specific affinity 
for the naturally occurring substrate acetyl-
choline, although it will hydrolyze several 
synthetic esters; and (2) the nonspecific 
enzyme, pseudocholinesterase, which has the 
ability to hydrolyze quite a wide range of 
naturally occurring and synthetic esters in 
addition to acetylcholine. Acetylcholinester-
ase occurs in the nervous system, where it is 
of great functional importance; in muscles; 
and in glands; and it also occurs incidentally 
in erythrocytes. The pseudoenzyme is found 
in the blood plasma and in various tissues, 
including the central nervous system. 
22 
In addition to location and substrate speci-
ficity, there are other differences between 
true and pseudocholinesterases. The latter 
functions well in the presence of an excess 
of substrate, while the former is inhibited 
under this condition. A number of inhibitors 
show considerable specificity for 8ne type of 
enzyme. For example, diisopropyl fluorophos-
phate (DFP) in low concentrations is almost 
completely specific for pseudocholinester-
ase.73 
It has been suggested that certain direct 
effects of the anticholinesterase organic 
phosphorus compounds do not depend on 
inhibition of cholinesterase.w5 Von Kaulla 
and Holmes 142 have reported that patients 
poisoned by organic phosphorus compounds 
show abnormalities in the blood-clotting 
mechanism, but the changes were in both 
directions from normal and must be consid-
ered unconfirmed. Some of the compounds 
do produce a delayed reaction similar to 
"J ake-Ieg paralysis," 11,41,94 but the clinical 
picture is quite distinct from that of ordinary 
poisoning. Although any statement about the 
relationship between cholinesterase inhibition 
and the classical picture of poisoning must be 
qualified in terms of the rate of depression, 
the degree of depression, and perhaps other 
factors, the evidence for a lack of relation-
ship is indefinite. On the contrary, the evi-
dence for a lack of relationship between 
cholinesterase inhibition and paralytic effect 
is much more clear. In spite of these excep-
tions, it is true that the predominant pharma-
cologic effect of the organic phosphorus 
compounds is inhibition of the enzyme acetyl-
cholinesterase. 
In order to have an understanding of the 
action of acetylcholinesterase and of the 
effect of its inhibition on the animal organ-
ism, it is first necessary to look at the physio-
logic action of acetylcholine. Acetylcholine is 
the chemical mediator of the parasympathetic 
nervous system and is necessary for trans-
mission of the nervous impulse (1) from 
preganglionic fibers to autonomic ganglia; 
(2) from postganglionic, cholinergic nerves 
to smooth and cardiac muscle and to secre-
tory cells: (3) from motor nerves to striated 
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muscle; and probably (4) from certain struc-
tures within the central nervous system. 
Normally, in the presence of the usual con-
centration of cholinesterase, the acetylcholine 
formed during the process of transmission 
is hydrolyzed almost instantly so that the 
synapse is again ready to transmit a physio-
logic impulse. A small abnormal accumula-
tion of acetylcholine at the synapse or 
myoneural junction produces an abnormal 
increase in function (e.g., fasciculation of 
muscle), while greater accumulation rapidly 
produces a decrease in function (e.g., paral-
ysis). A decrease in cholinesterase activity 
is accompanied by an accumulation of acetyl-
choline. The symptoms caused by organic 
phosphorus poisoning are, therefore, very 
similar to those resulting from overstimula-
tion of the parasympathetic nervous system. 
Symptoms of Organic 
Phosphorus Poisoning 
Absorption of the organic phosphorus 
anticholinesterases may occur through the 
lungs, gastrointestinal tract, or skin. Absorp-
tion of these materials is more rapid and 
more complete through the former 2 routes 
than through the latter. Respiratory exposure 
may be of predominant importance wherever 
there is a sufficient concentration of vapor 
or of aerosol fine enough to inhale. However, 
in many agricultural and public health usages, 
workers get contamination predominantly on 
their skins.13,3o,42 The oral route of 'exposure 
occurs in accidental poisoning (particularly 
of children), in murder, and in suicide. In-
gestion has not been considered of impor-
tance in occupational exposurt; but a case 
has been reported in which a parathion spray-
man became severely poisoned, presumably 
from eating a candy bar which he had been 
carrying for 6 hours in an open outside 
pocket of his work clothes.120 
Although many of the organic phosphorus 
compounds have a high acute toxicity, agri-
cultural residues of these materials on food 
have not been a problem, due to their rapid 
breakdown and the fact that they are not 
stored in the animal body.40 Direct contami-
nation of food by concentrated formulations 
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of these insecticides during shipment has 
been the cause of several outbreaks of poison-
ing in other countries. 
The symptom picture in organic phos-
phorus poisoning may vary in severity, in 
rapidity of onset, in duration, and in range, 
depending upon the route and the magnitude 
of exposure. Minor exposure to a vapor or 
aerosol of a direct inhibitor of cholinesterase 
may produce local effects on the eye or re-
spiratory system through local absorption 
and without systemic effect. The optic effects 
consist of miosis, a sensation of pressure in 
or behind the eye, headache, and conjunctival 
hyperemia. Unilateral manifestation of these 
optic effects has been implicated in visual 
difficulties experienced by pilots applying 
these materials.140 The local effects on the 
respiratory tract involve increased secretion, 
a feeling of tightness in the chest, and 
occasionally wheezing. Localized massive 
dermal exposure can lead to muscular fas-
ciculation and sweating confined to the area 
of absorption. 
Systemic effects may follow absorption by 
any route. If there has been adequate ex-
posure to a vapor or aerosol, the local respira-
tory effects already described will appear, 
but they will be rapidly followed by more 
severe optic and respiratory distress and 
by systemic manifestations. Dixon 38 has 
pointed out that too much reliance should 
not be placed on miosis as a diagnostic sign, 
since some poisoning cases, at least early in 
their course, do not exhibit miosis, and a few 
even have mydriasis. 
In systemic poisoning, the muscarine-like 
effects are usually first to appear. They in-
clude anorexia, nausea, sweating, epigastric 
and substernal tightness (probably due to 
cardiospasm), heartburn, belching, and tight-
ness in the chest. The sequence of symptoms 
varies somewhat with the route of exposure 
-gastrointestinal effects usually being ear-
liest after ingestion; sweating, and at times 
muscular fasciculations, after dermal ex-
posure; and respiratory effects after inhala-
tion. More severe exposure by whatever 
route produces abdominal cramps, increased 
peristalsis, vomiting, diarrhea, salivation, 
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lacrimation, profuse sweating, pallor, and 
dyspnea. In some subjects there is audible 
wheezing. More severe signs and symptoms 
include involuntary defecation and urination, 
excessive bronchial secretions, and (accord-
ing to some authors) pulmonary edema. 
Nicotine-like effects appear usually after 
the muscarine-like effects have reached mod-
erate severity. These include muscle twitch-
ing, fasciculations, and cramps. At about the 
same time, there appears increased fatigabil-
ity and mild, generalized weakness which is 
increased by exertion. Extensive exposure 
produces severe weakness, including weak-
ness of the muscles of respiration. There may 
be a mild or moderate elevation of blood 
pressure. 
The central-nervous-system effects include 
tension, anxiety, restlessness, giddiness, and 
emotional lability. Late effects include in-
somnia, excessive dreaming, and occasionally 
nightmares. Greater exposure produces head-
ache, tremor, drowsiness, difficulty in con-
centration, slowness of recall, and confusion. 
There may be withdrawal and depression. 
In the absence of symptoms, there is no 
change in the electroencephalogram {EEG).66 
Mild symptoms are accompanied by a slight 
diminution in potential, and moderate symp-
toms are accompanied by irregularity of 
rhythm, variation and increase of potential, 
and bursts of abnormal waves more or less 
reminiscent of waves seen in epileptics.107 
Lethal or near-lethal doses produce ataxia, 
slurring of words, multiple repetition of 
the last syllable of words, coma, areflexia, 
Cheyne-Stokes breathing, and finally, re-
spiratory arrest. 
The cause of death may usually be at-
tributed to interference with respiration.66 
Animal experiments have proved that the 
anticholinesterase organic phosphorus com-
pounds interfere with respiration in at least 
4 ways, including bronchoconstriction, ex-
cessive respiratory secretion, failure of the 
muscles of respiration, and depression of the 
respiratory center. Although the respiratory 
center is at first stimulated by anoxia of 
whatever cause, it is rapidly depressed by 
continued anoxia. The severe bronchial con-
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striction seen in animals following exposure 
to parathion or nerve gas has not been seen 
in man.66 The difference may depend on the 
different amount of bronchial musculature 
in different species. 
The compounds also produce bradycardia 
and various degrees of A-V block. If these 
effects are prevented by atropine, and if the 
animal is prevented from a respiratory death 
by artificial respiration, it will eventually 
succumb to a sufficient dose through dysfunc-
tion of the heart. This dysfunction will take 
the form of ventricular fibrillation if atropine 
should be administered in the presence of 
severe anoxia.1l;7 Even if atropine is given 
correctly, bradycardia and perhaps impaired 
contractility appear shortly before asystole 
in the animal maintained by artificial respira-
tion.83 Unanesthetized dogs, unlike anes-
thetized ones, exposed to sarin by various 
routes generally show bradycardia, increase 
in pulse amplitude, decrease in oxygen ten-
sion, increase in carbon dioxide tension, and 
fall in arterial blood pH before changes in 
respiratory rate and volume are evident.l;8.5lJ 
The local effects of organic phosphorus 
exposure begin within a few minutes after 
exposure and last for periods ranging from 
several hours to a day, except that miosis may 
last 2 to 5 days or occasionally longer. Mod-
erate systemic effects begin within about half 
an hour after respiratory exposure, three-
quarters of an hour after oral exposure, and 
2 to 3 hours after dermal exposure. With 
sufficient exposure, the onset of symptoms is 
essentially instantaneous, with death in a few 
minutes. Moderately severe symptoms may 
not reach their maximum until 4 to 8 hours 
after onset; they diminish over a period of 
1 to 6 days. However, EEG changes may 
persist for 11 to 18 days.66 
Mechanism of Inhibition 
of Cholinesterase 
In recent years, much has been learned 
about the molecular forces involved in the 
interaction of acetylcholinesterase both with 
its natural substrate and with organic phos-
phorus inhibitors.111 Wilson and Berg-
mann 153 have postulated that the surface of 
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the enzyme protein contains 2 active centers, 
an "anionic site" and a "cationic or esteratic 
site." The former, by means of coulombic 
forces, attracts the positively charged qua-
ternary nitrogen atom of acetylcholine and 
thereby fixes and orients the substrate in a 
proper position so that the esteratic site can 
exert its hydrolytic effect. The esteratic site 
is thought to consist of a hydrogen-bonding 
group which anchors the ester end of the 
acetylcholine molecule. It has been suggested 
that the ester-anchoring group may be the 
iminazole ring of histidine and that any phos-
phoryl group which becomes attached here 
is subsequently transferred to an adjacent 
serine moiety of the enzyme molecule by a 
N~O shift. It is thought that the effect of 
change in pH on the hydrolytic activity of 
this enzyme is mediated through changes in 
ionization at these 2 sites. 
In the following stage of the physiologic 
reaction, the acetylcholine is split into choline 
which is set free and the acetyl moiety which 
remains affixed to the enzyme. However, the 
acetylated enzyme is unstable and easily 
breaks down to form active enzyme and 
acetic acid. 
The reaction between enzyme and organic 
phosphorus inhibitor is thought to involve 
only the esteratic site, except with the phos-
phorylcholines 57 that are used as laboratory 
tools only and need not be discussed further. 
This center is phosphorylated to form a com-
plex which is, at least by contrast with the 
acetylated enzyme, quite stable. The phos-
phorylation is thought to proceed in 2 stages, 
as discussed in detail below under "Chemical 
and Physiologic Properties of Oximes." The 
stability of this phosphorylated enzyme ac-
counts for the fact that organic phosphorus 
compounds are inhibitors rather than sub-
strates for cholinesterase. During this inhibi-
tion reaction, the anionic site remains 
uninvolved. 
Measurement of Cholinesterase 
Activity and Its Relationship 
to Symptomatology 
Cholinesterase activity can be determined 
by any of several methods based on: (l) di-
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rect or indirect measurement of the acetic 
acid or other moiety released by hydrolysis 
of acetylcholine or other esters, or (2) direct 
measurement of acetylcholine remaining 
after partial hydrolysis. 
The electrometric method of Michel 107 to-
gether with a micromodification of this tech-
nique for use with capillary blood samples 104 
is probably the most widely used method. 
There are also available colorimetric,W6 titri-
metric,18 and manometric 1 procedures. The 
colorimetric screening method of Limperos 
and Ranta 100 is adaptable to the approximate 
determination of large numbers of samples 
under field conditions. Other procedures in-
volve use of the Hestrin method 75 for meas-
urement of acetylcholine. 
The restoration of plasma or of plasma 
and red blood cell cholinesterase activity may 
be increased by plasma or whole blood trans-
fusions in animals without any effect on the 
symptoms of poisoning or appreciable re-
duction in the susceptibility to further ex-
posure.14 
Although the acetylcholinesterase of red 
blood cells and the more general esterase of 
the plasma are not directly related to the 
signs and symptoms of organic phosphorus 
poisoning, these enzymes are inhibited in a 
manner essentially parallel to the inhibition 
of acetylcholinesterase of nerve, muscle, and 
gland. The blood enzyme levels, and partic-
ularly that of the erythrocytes, may be used 
as an index of tissue enzyme levels. The 
erythrocyte cholinesterase level has been 
shown to correlate rather closely with the 
activity of this enzyme in the brain during 
both poisoning and recovery in the rat.60 
Following a single exposure, maximum de-
pression of blood cholinesterase occurs 
within a few hours. The degree of depression 
varies with the amount of absorption, the 
logarithm of the fraction of enzyme inhibited 
being proportional to the amount of toxicant 
absorbed in connection with essentially in-
stantaneous dosage. Of course, absorption is 
influenced by route, often being prolonged 
for hours or even days after skin exposure. 
Multiple exposures over a brief period are 
partially cumulative in their effect. Experi-
Durham-Hayes 
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ence suggests that small multiple exposures 
over an extended period are not indefinitely 
cumulative in their effects but that the cholin-
esterase level reaches a plateau.74,135 There 
is some evidence that the rate of inactivation 
of tissue cholinesterase, as well as the degree 
of inhibition, may influence the level of tissue 
enzyme activity at which symptoms begin. 
The cholinesterase activity of the red blood 
cells may be gradually depressed to near zero 
by repeated exposure over a period of weeks 
without systemic symptoms necessarily en-
suing, or without any relation to the severity 
of symptoms that occur.127,135 
Following exposure, the blood enzymes, 
especially the erythrocyte cholinesterase, re-
main at a low level of activity for some time 
after the disappearance of symptoms. This 
lag is thought by some to indicate that cholin-
esterase activity is restored more rapidly in 
the tissues than in the blood, although the 
tissue regeneration rate is not fully known. 
Chronic-feeding and certain other studies 
indicate that the phenomenon may be ac-
counted for by tolerance rather than by a 
difference of recovery rate for different en-
zymes.127 The adaptation to constant concen-
trations of acetylcholine that has been 
demonstrated to occur in ganglia 98 may well 
occur in other parts of the nervous system. 
This adaptation almost certainly contributes 
to the lack of parallelism between symptom-
atology and cholinesterase level. 
It is true that effects of doses of anticholin-
esterase compounds near the fatal level are 
partially cumulative if the doses are repeated 
at relatively brief intervals. Thus, Callaway 
and Davies 21 have found in rabbits and 
guinea pigs that lowering the blood cholin-
esterase level to 50% of normal by either a 
single dose or repeated doses of tetraethyl 
pyrophosphate (TEPP) or sarin results in 
an increased susceptibility of the animal to 
these agents. 
Plasma cholinesterase is formed by the 
liver. Following cessation of exposure, plas-
ma enzyme activity is increased by about 
13% of original activity during the first day, 
and more slowly thereafter, so that 30 to 40 
26 
days are required to reach the normal pre-
exposure level. 
Once fully inhibited, the enzyme content 
of a particular erythrocyte is not regenerated. 
Rather, in the absence of treatment with 
oximes, the rate of regeneration of red-
blood-cell cholinesterase reflects the replace-
ment of red corpuscles in the circulation and 
thus requires 90 to 100 days to return to 
original activity after nearly complete depres-
sion. Regeneration occurs at a regular rate 
of about 1% of normal per day. 
Barstad 12 concluded that respiratory func-
tion should be only slightly impaired by a 
peripheral cholinesterase inhibition ap-
proaching 90% and that consequently a 
rather slight degree of cholinesterase reac-
tivation at the critical site should be sufficient 
to relieve the peripheral failure of respira-
tory movements during poisoning with anti-
cholinesterase agents. 
Measurement of Metabolites 
and Their Relationship 
to Symptomatology 
Exposure to those organic phosphorus 
compounds which, on hydrolysis, form 
p-nitrophenol or one of its congeners can 
be estimated by determination of these phe-
nolic compounds in urine.45 Although ap-
plicable to a restricted group of compounds, 
this test has proved to be a more sensitive 
measure of absorption than is cholinesterase 
inhibition.4 A urine test based on excretion 
of organically-bound phosphorus would be 
desirable, since metabolites of this type are, 
of course, common to all the compounds in 
this group. 
Use and Action of Atropine and 
Other Nonspecific Antidotes 
Until recently, the most important factors 
influencing survival after otherwise lethal 
cholinesterase inhibition appear to be prompt 
administration of atropine in sufficient dos-
age and artificial respiration, if required.61 
The suggested dose of atropine is 2 mg. 
initially, and as much as 6 mg. may safely be 
given within lO minutes or more without 
medical supervision. Individuals poisoned by 
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anticholinesterase organic phosphorus com-
pounds have an increased tolerance for atro-
pine. Furthermore, a single dose of as much 
as lO mg. of atropine has been inadvertently 
administered intravenously to normal adults 
without endangering life, although it has, of 
course, produced very marked signs of over-
dose. In the presence of severe anticholines-
terase poisoning, 40 mg. of atropine may be 
given in a day without producing symptoms 
of overatropinization. The low toxicity of 
atropine and its effectiveness in the treatment 
of anticholinesterase intoxication have been 
discussed by Gordon and Frye.65 
Severe symptoms of organic phosphorus 
poisoning should be treated by the physician 
with the intravenous injection of 2 to 4 mg. 
of atropine. The effects of intravenous atro-
pine begin in 1 to 4 minutes and are maximal 
within 8 minutes. If muscarine-like symp-
toms are not relieved, and if signs of atropin-
ization (dry, flushed skin and tachycardia) 
do not appear, the intravenous injection of 
atropine in doses of 2 mg. should be repeated 
at 5- to lO-minute intervals until symptoms 
are relieved or signs of atropine overdosage 
appear. A mild degree of atropinization 
should be maintained in all cases for 24 hours 
and in severe cases for at least 48 hours. 
Atropine should not be given to an anoxic 
patient because of the danger of producing 
ventricular fibrillation. In the cyanotic pa-
tient, artificial respiration, oxygen, or other 
indicated measures should be carried out first 
to correct the anoxia, and then atropine 
should be given. 
Atropine should not be administered for 
preventive purposes in persons who antici-
pate exposure to anticholinesterase agents. 
Its use in this manner may mask the early 
occurrence of signs and symptoms of intoxi-
cation and allow the patient to expose himself 
to dangerous levels of the toxicant without 
warning. Wills 145 has noted that animals 
given atropine before respiratory exposure 
to sarin 'vapor were somewhat more sus-
ceptible to the poison than controls given no 
antidote. The ineffectiveness of atropine in 
this situation was interpreted as being due 
to its action to prevent the bronchoconstric-
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tion which otherwise occurs to some degree 
after inhalation of nerve gas vapor (see 
"Symptoms of Organic Phosphorus Poison-
ing" ), there fore resulting in greater inhala-
tion and absorption from the respiratory 
tract. Patients who are sick enough to receive 
atropine should be hospitalized and kept un-
der careful observation for 24 hours; in some 
instances, a marked improvement has been 
noted after atropine followed later by de-
terioration of the patient's condition, requir-
ing further treatment promptly.71 
Ocular symptoms produced by local ab-
sorption do not respond to the systemic ad-
ministration of atropine but are relieved by 
the local administration of 2% homatropine 
or, if severe, by the local administration of 
0.5% or 1 % atropineYi7 Parenteral atropine 
may relieve miosis, but the effect is both ir-
regular and transient. I f local ocular effects 
are present, the size of the pupils obviously 
cannot be used as an indicator of systemic 
poisoning or as a gauge for atropine dosage. 
If convulsions interfere with artificial 
respiration and are not relieved by intrave-
nous atropine, the patient may be given 
trimethadione (Tridione), a barbiturate, or 
ether. Trimethadione may be given intrave-
nously or intramuscularly, in doses of 1 gm., 
repeated if necessary. Morphine should not 
be given. The action of succinyl choline 
( Suxamethonium) increases the effect of the 
anticholinesterase agents, and thus the use of 
this relaxant is contraindicated (see "Chem-
ical and Physiologic Properties of Oximes"). 
Results of treatment using transfusion 
with normal blood or even intravenous in-
fusion of purified cholinesterase have, in 
general, been disappointing.14 It is doubtful 
whether these materials provide any active 
enzyme to important sites in the nervous tis-
sue. Their action in combining with any cir-
culating poison is too little and too late to be 
of value in reversing the pathology associated 
with poisoning. 
It is important to understand that, while 
atropine is effective as an antidote, it has no 
effect on the fundamental biochemical lesion 
involved in poisoning by anticholinesterase 
compounds. Atropine merely serves to block 
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certain actions of the excess acetylcholine 
already accumulated. Atropine has no action 
on the nicotonic effects of acetylcholine, in-
cluding the neuromuscular block that leads 
to muscle weakness, and may finally end in 
death due to paralysis of the respiratory mus-
cles.14li Although atropine specifically blocks 
the muscarinic actions of acetylcholine, it is 
less effective in blocking certain muscarinic 
actions (such as those on the intestine and 
urinary bladder) than others (such as cardiac 
slowing and sialorrhea). The effects of anti-
cholinesterases on the central nervous system 
are reversed by atropine, and the increased 
electrical activity of the brain, as shown by 
the EEG, is returned to normal.1li7 
Tests with various synthetic parasympa-
tholytic agents, including l-N-butylscopolam-
monium bromide (Buscopan) ,37 have not 
shown any of these compounds to be signif-
icantly more effective than atropine in anti-
dotal action. 
Development of Specific Antidotes 
Numerous investigators have sought to 
find agents that would interfere in the com-
bination of the organic phosphorus com-
pound with cholinesterase or hasten the 
destruction of the inactive phosphorylated 
enzyme complex. The deVelopment of specific 
antidotes of this type has been reviewed by 
Davies and Green.33 The role of oximes in 
the treatment of anticholinesterase poisoning 
has also been reviewed by Wills 145 and by 
Verhulst and Page.141 
Probably the usage of physostigmine 
(eserine) and neostigmine 26,70 represents 
the earliest record of such attempts. It was 
found that, instead of an expected summa-
tion or potentiation of effect occurring 
between DFP and physostigmine or neostig-
mine, prior administration of one of the lat-
ter agents protected rats against lethal doses 
of DFP. It was postulated that this antidotal 
effect was due to the formation between the 
physostigmine or neostigmine and cholin-
esterase of an unstable bond which served to 
protect the active site on the enzyme from 
attack by the irreversible inhibitor, DFP. 
The effectiveness of these particular agents 
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is strictly prophylactic, and they have no 
antidotal effect when given after the poison. 
An additive rather than an antagonistic ac-
tion was noted when physostigmine was 
given after DFP 97 or parathion.129 
Somewhat later, Wilson 148,149 reported 
that choline and hydroxylamine were effective 
in reversing the combination between cholin-
esterase and certain organic Qhosphorus 
inhibitors. Wagner-Jauregg and his co-work-
ers 144 used certain metal salts and chelates 
to reactivate DFP-inhibited enzyme. 
The most promising development, how-
ever, is that associated with the hydroxamic 
acids and oximes.150 As pointed out above, 
it has been shown that the organic phos-
phorus compounds inactivate cholinesterase 
by forming a firm bond with the enzyme. 
This combination is commonly spoken of as 
"irreversible" in contrast to the combination 
of cholinesterase with physostigmine or neo-
stigmine, which can easily be reversed by 
dilution or dialysis. Actually, "irreversible" 
must be regarded here as a relative term. In 
fact, TEPP-inactivated enzyme spontane-
ously recovers some of its activity in vitro 
if allowed to stand in water for a sufficiently 
long time. It is more difficult to reactivate 
DFP-inhibited enzyme. 
It would be expected that reagents (such 
as esters or acids) capable of making a nu-
cleophilic attack on the phosphorus atom 
of the inhibitor-enzyme complex could re-
generate the enzyme. Theory would further 
predict that presence within the reactivating 
molecule of a cationic structure, such as the 
ammonium radical, would facilitate this re-
action by acting, as does the nitrogen atom 
in acetylcholine, to properly position the 
molecule for its reaction with the enzyme. 
The hydroxamic acids and oximes fulfill 
these requirements imposed by theory by 
having both nucleophilic and cationic am-
monium groupings in the molecule. 
The mechanism of action of oximes in re-
generating inhibited cholinesterase is thought 
to consist of an initial direct combination 
between the organic phosphorus-inhibited 
enzyme and the hydroxamic acid, followed 
by a reaction in which the organic phos-
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phorus moiety is split off and hydrolyzed. 
The hydroxamic acid residue undergoes a 
further reaction to regenerate the active en-
zyme. The important thing from a practical 
standpoint is that the hydroxamic acid has 
a greater affinity for the phosphorus moiety 
than does the enzyme. 
Epstein and Freeman 46 have reported the 
results of a study of the toxicity and prophy-
lactic and therapeutic efficiency of a series 
of 15 hydroxamic acids in nerve-gas poison-
ing in mice. Other workers at the Army 
Chemical Center 39 have made and tested 22 
oximes in this regard. O'Leary et al. 118 have 
tested a number of oximes both singly and 
in various combinations. 
Of the hydroxamates and oximes tested 
by various workers, the outstanding com-
pounds are 2-pyridine aldoxime methiodide 
( 2-PAM iodide) and related salts. These 
compounds combine the features of low 
mammalian toxicity and good prophylactic 
and therapeutic efficiency against organic 
phosphorus poisoning. 
Details regarding usage of oximes, and 
particularly of 2-PAM salts, in the treatment 
of anticholinesterase poisoning are consid-
ered in succeeding sections of this review. 
2-Pyridine aldoxime methyl methanesulfonate 
(P2S), which is the methane sulfonate salt 
corresponding to 2-PAM, has recently been 
shown to be just as effective therapeutically 
as 2-P AM iodide 35 and to possess the ad-
vantage of greater water solubility.34 The 
methochloride salt of 2-pyridine aldoxime 
(2-P AM chloride) is more stable and more 
water soluble than 2-PAM iodide. The 
methochloride salt is now commercially avail-
able in the United States as an investigational 
drug under the trade name Protopam. * The 
lactate salt has been studied by O'Leary 
et alY8 
In comparing the effects of these various 
salts of 2-pyridine aldoxime, it is necessary 
to take into account the variation in the 
* From Campbell Pharmaceuticals, Inc., 121 E. 
24th St., New York 10. (The use of trade names 
is for identification purposes only and does not 
constitute endorsement by the Public Health 
Service.) 
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amount of actual free base in the dosage ad-
ministered. For example, 1.0 gm. of 2-PAM 
chloride is approximately equal to 1.5 gm. of 
2-PAM iodide with regard to content of the 
active free-base, 2-pyridine aldoxime. 
British workers 5,23,128 have proposed 
monoisonitroacetone (MIN A) and diacetyl-
monoxime (DAM) as being superior to 
2-PAM in combating organic phosphorus 
poisoning. DAM is less toxic than 2-PAM.6 
These oximes reactivate sarin-inhibited cho-
linesterase in vitro and are effective antidotes 
for sarin poisoning in rats. Robbiger and his 
co-workers 79·81 have tested a series of 18 
pyridinium oximes against TEPP and DFP 
both in vitro and in vivo. They reported that 
certain monoximes and dioximes of poly-
methylenebispyridinium compounds were 
from 15 to 52 times as potent as 2-PAM. 
Poziomek et al.llt) have also synthesized a 
number of compounds in this series. The 
outstanding antidotal compound from this 
group is 1,1'-trimethylene-bis(4-formyl-pyri-
dinium bromide) dioxime (TMB_4).15,52,711.81 
These other oximes have not been studied so 
thoroughly as the salts of 2-PAM. 
Another type of specific antidote which 
should be mentioned includes compounds 
which increase the hydrolytic activity of cho-
linesterase. Among the compounds which 
have been shown in vitro to possess this sort 
of activity are tryptamine,50 certain anal-
gesics,53 and other compounds.55,72,139 Most 
of this work has been carried out with plasma 
cholinesterase, although some studies using 
the specific enzyme have been done.11o,134,137 
There is, at present, little or no indication 
that these agents would be of practical value 
in the treatment of poisoning. 
Ball and his co-workers 10 found that rats 
which had been given a large but sublethal 
dosage of aldrin were able to withstand 
amounts of parathion that would ordinarily 
be lethal. This protective effect of aldrin was 
accompanied by an increased plasma cholin-
esterase level. Similar results have been noted 
with other chlorinated hydrocarbon insecti-
cides, including chlordane, dieldrin, DDT, 
heptachlor, and the a and y isomer (lindane) 
of benzene hexachloride (BRe) .21},115 Other 
Durham-Hayes 
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known hepatotoxic agents (such as carbon 
tetrachloride) have a similar action. The 
transitory rise in serum esterase apparently 
is a temporary consequence of the tissue 
damage occurring in the liver. Since the pro-
tective effect has been noted for a direct 
inhibitor (TEPP) as well as for compounds 
which must undergo biotransformation in 
order to bet:ome toxic, a decreased activating 
ability of the liver would not seem to be the 
mechanism of action. The most likely possi-
bilities appear to be an increased level of 
phosphorylatable enzyme which competes 
with the true cholinesterase for the inhibitor, 
or an increased level of hydrolyzing enzyme 
which aids in the degradation of the anti-
cholinesterase. O'Brien 116 considers the lat-
ter possibility to be more likely. 
Many of the organic phosphorus com-
pounds (including parathion, the other phos-
phorothioates, and some phosphoroamidates) 
become potent anticholinesterase agents only 
after bioactivation by the liver.116 It has 
proved possible to protect animals from com-
pounds of this type by blocking the activating 
enzymes present in the liver. Thus, Davison 36 
was able to protect mice from poisoning by 
octamethyl pyrophosphoramide (OM P A) 
but not by parathion through prior adminis-
tration of the liver microsome inhibitor SKF 
525A (,8-diethylaminoethyl diphenylpro-
pylacetate hydrochloride) . O'Brien and 
Davison 117 studied other liver microsome in-
hibitors, but found SKF 525A to be the best 
of 12 agents tested. They confirmed the fail-
ure of SKF 525A to protect against para-
thion but found that it antagonized Guthion 
insecticide poisoning. The lack of effective-
ness of SKF 525A against parathion poison-
ing has not been satisfactorily explained. The 
failure does not seem to represent a general 
ineffectiveness against phosphorothionates, 
since the LD50 of Guthion was increased. 
In connection with this effect on the enzyme 
system which activates the organic phos-
phorus insecticides, it is interesting to note 
that compounds are also known which inhibit 
the enzyme systems that detoxify the organic 
phosphorus compounds. Among the com-
pounds producing this effect are certain of 
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the organic phosphates themselves. Thus, 
when given in combination, the resultant toxic 
action of certain of the organic phosphorus 
compounds is greater than would be ex-
pected on the basis of simple additive effect.1I6 
This potentiation was first reported for mala-
thion plus ethyl-p-nitrophenyl thionobenzene 
phosphonate (EPN),1i6 while the maximum 
synergistic effect (88 to 134 times.) noted has 
been observed with malathion plus triortho-
tolyl phosphate TOTP .109 The mechanism by 
which potentiation occurs has been elucidated 
and appears to involve the interference of 
one compound with the metabolism of the 
Chemical Name 
B;ydroxyl amine 
Pyridine-2-alddxime 
methiodide 
Pyridine-2-aldoxime 
methochloride 
Pyridine-2-aldoxime 
methyl methanesulfonate 
Diacetylmonoxime 
MOnoisonitrosoacetone 
I,ll-trimethylene 
bis(4-formyl-pyridinium 
bromide) dioxime 
Common Name 
2-PAM or 
2-PAM iodide 
2-PAM chloride 
or Protopam 
P2S 
DAM 
MINA 
THB-4 or 
TMB-4 dibromide 
Structural Formula 
Same as above except 
chlorine salt 
Chemical name, common name, and structural formula of oximes used as antidotes in poison-
ing by anticholinesterases. 
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Toxicity of Oximes to Experimental Animals 
Compound Species Sex 
2-P AM Iodide Mouse Mixed 
2-P AM Iodide Mouse Mixed 
2-P AM iodide Mouse Unstated 
2-PAMiodide Meuse Unstated 
2-P AM iodide Mouse Unstated 
2-PAM sulfonate Mouse Unstated 
2-PAM chloride Mouse Unstated 
2-P AM chloride Rabbit Mixed 
TMB-4 dibromide Mouse Unstated 
TMB-4 dlcbloride Mouse Unstated 
TMB-4 dichloride Rabbit Mixed 
second.27.28.109 Seume and O'Brien 133 have 
reported that inhibition of carboxyesterase 
and carboxyamidase is important in potentia-
tion of these compounds. 
A potentiating effect between certain of the 
organic phosphorus insecticides and some 
phenothiazine-derived tranquilizers has been 
found to occur in rats 64 and has been sus-
pected to occur in man.3 
It has been noted that the signs and symp-
toms of parathion poisoning were intensified 
and prolonged in a patient who was given 
succinylcholine for control of convulsions.12o 
Chemical and Physiologic 
Properties of Oximes 
The chemical structure of 2-PAM iodide 
is shown in the Figure. The similarity of 
the aliphatic portion of this molecule to 
hydroxylamine is apparent. Pure 2-PAM 
iodide is a yellow, crystalline solid which de-
composes at 219 C. It is soluble in water up 
to about 5% and practically insoluble in ethyl 
alcohol. Themethanesulfonate salt (P2S) is 
soluble in water up to about 40%.34 The 
chloride is soluble in water to the extent of 
1.0 gm. in less than 1.0 ml. 
The toxicity to laboratory animals of vari-
ous oximes as determined by a number of 
different investigators is summarized in the 
Table. It can be seen that the estimate of the 
intraperitoneal LDso of 2-PAM iodide to 
mice ranges from 136 to 223 mg. per kilo-
gram, and the intravenous LD50 ranges from 
44 to 145 mg. per kilogram for mice and 
rabbits. The toxicity of the compound, while 
important, is not especially great. When lethal 
Durham-Hayes 
LD .. 
Route mg/kg Reference 
Intraperitoneal 136± 6 92 
Intraperitoneal 223±10 102 
Intr" peritoneal 209±22 160 
Subcutaneous 140±15 160 
Intravenous 145± 8 118 
In tra ven ous 118±13 118 
Intravenous 115± 3 118 
Intravenous 95 118 
Intravenous 53± 5 118 
Intravenous 57± 1 118 
Intravenous 44 118 
doses are given, death usually occurs within 
10 to 20 minutes and is due to respiratory 
failure. Generalized clonic convulsions and 
gasping respiratory movements are seen. 
Generalized skeletal muscle tremors continue 
for a few minutes after cessation of respira-
tion. The similarity of this symptom picture 
to that seen in organic phosphorus poisoning 
leads one to suspect that the mechanism of 
toxic action of 2-PAM may involve its ob-
served capacity to inhibit cholinesterase in 
excess dosages (see further details on 
page 34). 
In man, side-effects from the oximes 
2-PAM iodide, 2-PAM chloride, and dia-
cetylmonoxime (DAM) have been minimal 
in normal subjects and practically nonexistent 
in people who were poisoned.68.69.87 Rapid 
intravenous injection of 2-PAM iodide has 
produced transient mild weakness, diplopia, 
blurred vision, dizziness, impairment of ac-
commodation, and occasionally headache, 
nausea, and tachycardia.87 A few patients 
given 2-PAM iodide have complained of a 
bitter taste that no doubt resulted from the 
iodine moiety of the molecule; 2-PAM iodide 
has also produced an allergic rhinitis and a 
feeling of fatigue in the jaws,11a 
Intravenous injection of DAM has caused 
a burning sensation at the site of injection 
radiating up the vein, giddiness, drowsiness, 
a sensation of warmth and tingling in the 
abdomen and chest, tachycardia, mild pos-
tural hypotension,68 and occasionally bitter 
taste, paresthesias and decreased position 
sense in the extremities, decreased sweating, 
transient loss of consciousness, clonic move-
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ments of the head, and decreased amplitude 
of the electroencephalogram and of the T-
wave segment of the electrocardiogram.87 
Many of the oximes liberate cyanide in the 
body and also on long standing in vitro.8,11l 
When there is doubt concerning the integrity 
of a 2-PAM preparation, particularly solu-
tions of old or uncertain age, a simple test 
for free cyanide should be carried out. 
lt should be noted that 2-PAM salts have 
at least 3 actions which may be of importance 
in their effect on animals poisoned by organic 
phosphorus compounds. These actions are: 
1. Reactivation of inhibited cholinesterase. 
2. Reaction with and inactivation of the organic 
phosphorus molecule. 
3. Inhibition of cholinesterase, especially in excess 
dosage. 
The reactivation of inhibited cholinesterase 
is the dominant effect of 2-PAM in poisoned 
animals. In vitro, 2-PAM is a very powerful 
reactivator. At a concentration of 1O-5M., 
2-PAM iodide reactivates as much as 80% 
of alkyl phosphate-inhibited enzyme within 
1 minute.154,31,23 The diisopropyl phospho-
rylated enzyme is reactivated more slowly and 
less completely than the diethyl substituted 
cholinesterase.77 In a comparative in vitro 
study of 2-PAM iodide, DAM, and mono-
isonitroacetone (MIN A), Cohen and Wier-
singa 24 found that 2-PAM iodide was the 
most efficient reactivator, followed closely by 
MINA. The reactivation by DAM was slow 
when compared with those of the 2 other 
oximes. In a later paper, Cohen and Wier-
singa 25 theorized that the antidotal efficacy 
of DAM was primarily due to its ability to 
inactivate the organic phosphorus molecule 
rather than its capacity to regenerate inhibited 
cholinesterase. Rajapurkar and Panjwani 124 
suggested that DAM had an antiacetylcholine 
effect, like that of atropine. Their hypothesis 
was based on study of ciliary movement in 
the frog esophagus. This preparation has 
been shown to contain the acetylcholine-
cholinesterase-choline acetylase system, but 
no nervous tissue. DAM produced slowing 
of the ciliary movement similar to that pro-
duced by atropine or curare. The action was 
the same in eserinized or normal cilia. Thus, 
apparently neither a central mechanism nor a 
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reactivation of inhibited enzyme was respon-
sible for the effect of DAM in this instance. 
Kewitz 90 has shown that 2-PAM iodide 
reactivates the esterase activity of diaphragm 
in the living animal poisoned with paraoxon 
or DFP, but not OMP A. These results paral-
lel those obtained in vitro with the same com-
pounds and afford good evidence that the 
antidotal properties of 2-PAM depend upon 
reactivation of inhibited cholinesterase. 
Cohen and Wiersinga 215 reported that both 
MINA and 2-PAM iodide rege'1erated dia-
phragm cholinesterase in vivo in sarin-
poisoned rats. Inhibited brain cholinesterase 
was reactivated by MIN A only. 
Some workers 7,78 have not been entirely 
satisfied with this explanation for the anti-
dotal efficacy of 2-PAM, and, in support of 
their view, point out that the therapeutic 
efficacy and in vitro cholinesterase reacti-
vating power of the oximes do not correlate 
very closely. One would do well to remember, 
however, that the other 2 actions of oximes 
(numbers 2 and 3 above) must also be con-
sidered and may explain the observed lack 
of correlation. 
In contrast to the marked rise of enzyme 
activity in blood and muscle following the 
administration of 2-PAM, little or no effect 
has been noted on inhibited brain cholinester-
ase.78,128,1l0,91,25 This failure of 2-PAM to 
reactivate brain cholinesterase has usually 
been ascribed to a supposed inability of the 
oxime to pass the blood-brain barrier. In 
earlier work, Koelle and Steiner 96 had shown 
that quaternary nitrogen compounds pene-
trate the blood-brain barrier with difficulty. 
However, even when administered intracis-
ternally, P2S had no effect on the central 
actions of sarin. Holmstedt 84 considered that 
the observed failure of 2-PAM iodide to 
restore respiration depressed by anticholin-
esterase was due to its inability to penetrate 
the blood-brain barrier. Jager et a1.88 found 
low concentrations of 2-P AM iodide in the 
brain of 2 rabbits infused with this antidote. 
Wilson 152 has attempted to overcome this 
difficulty by using the fat-soluble dodecanoic 
acid analogue of 2-PAM with only partial 
success. In contrast to these results, Rosen-
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berg 126 has noted in vivo reactivation of 
brain cholinesterase by 2-PAM iodide after 
paraoxon poisoning in the rabbit. Rosenberg 
considered that the differences between his 
results and those of others cited above might 
be due to species variation or to the use of 
different extraction procedures. Differences 
in dosage levels of 2-PAM may also have 
been a factor, since Rosenberg gave very high 
dosages (up to 250 mg. per kilogram). 
The marked effectiveness of 2-PAM 
iodide, 2-PAM chloride, and TMB-4 in 
poisoning by Phospho line Iodide in mice is 
considered to be related to the fact that phos-
pholine, in contrast to other organic phos-
phorus cholinesterase inhibitors, contains a 
quaternary nitrogen atom, and thus, like the 
quaternary oximes, fails to pass the blood-
brain barrier.911 
TMB-4 did not reactivate brain cholin-
esterase activity in rats poisoned with DFP 
or sarin.51 
Jager et al. 88 were not able to demonstrate 
2-PAM iodide in the cerebrospinal fluid in a 
man who received 44 mg. per kilogram of 
this oxime intravenously. However, rapid re-
turns to consciousness following administra-
tion of 2-P AM iodide have been noted in 
patients poisoned with parathion. 811,49,121 This 
clearing of consciousness would seem to be 
an indication that the drug has access to the 
brain in man. The practical clinical result 
may be further evidence for species variation 
in the action of 2-PAM. 
In contrast to the peripherally-acting qua-
ternary oximes (2-PAM and TMB-4), the 
nonquaternary oximes have a predominantly 
central action.146,19 DAM has been shown 
to penetrate the blood-brain barrier and effect 
some reactivation of brain cholinesterase.88,43 
However, DAM in large doses has produced 
coma in man.87 
O'Leary et al.118 have reported that atro-
pine and a combination of a mono quaternary 
and a bisquaternary oxime were superior to 
atropine with either single type of oxime in 
dogs and rabbits poisoned with sarin or 
tabun. AI: 1 mixture of 2-P AM chloride and 
TMB-4 dichloride was the most effective 
combination tested. Edery and Schatzberg-
Durham-Hayes 
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Porath 44 have noted synergIsm between 
2-P AM and DAM. 
At any given dosage with any given inhibi-
tor and reactivator, the extent of reactivation 
of cholinesterase activity that occurs depends 
upon how long the inhibitor and enzyme have 
been left in contact.76 Hobbiger theorized that 
the phosphorylation of cholinesterase led in-
itially to an unstable phosphorylated enzyme 
which gradually changed to an irreversibly 
phosphorylated enzyme. This phenomenon 
has been termed "aging" by O'Brien 116 and 
has been shown to occur in vivo 78 as well as 
in vitro.151 ,32 Aging occurs rather slowly with 
methylphosphorylated cholinesterase, but 
more rapidly with diethyl- or diisopropyl-
substituted enzyme.32 These results indicate 
that the oximes might be less effective in 
regenerating- cholinesterase inhibited during 
repeated exposure than that inactivated after 
a single exposure. 
The use in vitro of a reactivator in the 
routine cholinesterase test has been proposed 
to allow determination of both inhibited and 
normal enzyme levels in a single blood sample 
from a patient in whom poisoning is sus-
pected.3 The occurrence of aging would seem 
to make achievement of this objective un-
likely in connection with repeated exposure; 
but it should be possible, by use of a similar 
technique, to differentiate between an inhibi-
tion of cholinesterase due to a recent, acute 
exposure and a depression due to a previous 
or repeated exposure. 
Direct reaction between 2-PAM and the 
organic phosphorus molecule has been shown 
to occur.143,T7 The importance of this reaction 
in either the prevention of dermal absorption 
or local effects of anticholinesterase com-
pounds or both has been discussed by 
Summerson.159 Kewitz, Wilson, and Nach-
mansohn 93 have, however, pointed out that 
it is unlikely that the direct reaction is an 
important factor in the antidotal action on 
systemic effects in vivo, since in vitro experi-
ments have shown that this direct reaction 
is very slow at concentrations obtainable 
under physiological conditions. These authors 
note that even with a 1O-3M. concentration 
of 2-PAM iodide at 25 C, pH 7.8, only about 
34 
1 % of diethyl p-nitrophenyl phosphate 
(Paraoxon, 1O-4M.) reacts per hour. Cohen 
and Wiersinga 25 found that both DAM and 
MINA detoxified sarin during in vitro incu-
bation. No detoxication of sarin by 2-PAM 
iodide occurred. These authors suggested 
that DAM acts mainly by virtue of direct 
reaction with the toxicant, that 2-PAM acts 
primarily by reactivating inhibited enzyme, 
and that MINA shows both types of activity. 
At sufficiently high dosages, 2-PAM iodide 
is capable of inhibiting both serum and eryth-
rocyte cholinesterase in vitro.8'2.T7.68 Although 
the antidotal dosages which have generally 
been used are below the toxic level, there 
would seem to be, on the basis of studies 
reported by Loomis,102 a definite possibility 
of lessened antidotal effect if greater than 
the optimal dose of 2-PAM were given. This 
author noted that dogs given an intravenous 
dose of 60/Lg. of sarin per kilogram required 
more than 240 minutes to recover their nor-
mal response to injected acetylcholine. Fol-
lowing intravenous administration of 10, 25, 
or 250 mg. per kilogram of 2-PAM iodide 
to normal dogs, <2, 3, and > 120 minutes, 
respectively, were required for return of the 
normal acetylcholine response. The same 
dosage levels of 2-P AM iodide when given 
to sarin-poisoned dogs, produced return to 
normal acetylcholine response after 40 to 45, 
80 to 100, and > 120 minutes, respectively. 
These results indicate that 2-PAM iodide 
is a cholinesterase inhibitor, that 10 mg. per 
kilogram was the optimum antidotal dosage 
under the condition of the test and that larger 
doses were less effective. 
Woodard 158 gave 50 mg. per kilogram of 
2-P AM iodide to cattle intraperitoneally and 
intravenously. This dosage produced some 
restlessness and mild abdominal distress, but 
the signs were mild and of short duration. 
One sheep given 25 mg. per kilogram of 
2-PAM iodide intravenously showed the 
same signs as the cattle, plus an increased 
respiratory rate and excessive salivation. 
No change in erythrocyte cholinesterase level 
was observed in any of these animals. 
The cholinesterase inhibitory activity of 
2-PAM has also been noted by Bergner and 
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Wagley.16 These workers reported that 
2-PAM iodide in high concentration in vitro 
had a dual effect on motor end-plate cholin-
esterase previously inactivated by TEPP. 
The 2-PAM iodide reactivated the enzyme 
and, if allowed to remain in contact with the 
preparation, inhibited the reactivated enzyme. 
It is important to note that in poisoned 
people given therapeutic doses, the inhibition 
of cholinesterase by 2-PAM is trivial, while 
the release of enzyme inhibited by the organic 
phosphorus compound is highly significant. 
Kewitz et al.lI3 have carried out experi-
ments which show that 2-PAM does not have 
an atropine-like action. In studies on the 
blood pressure of eviscerated cats, the effect 
of acetylcholine was not modified by 2-PAM 
iodide, even when large doses were used; 
this effect was completely abolished by a small 
dose of atropine, however. After 100 mg. 
per kilogram of 2-PAM iodide, these authors 
reported a rise in blood pressure from 120 
to 160 mm. Hg which lasted 15 to 20 minutes 
and was abolished by atropine. This effect 
from the very large dose of 2-PAM iodide 
was not further studied. Possibly, it was a 
reflection of the cholinesterase inhibitory 
effect of 2-PAM. 
Both 2-PAM iodide and DAM, when in-
jected intravenously in large doses, have a 
direct depressant action on the respiratory 
center.156 
The duration of action of a single dose of 
2-PAM has been studied by Kewitz et al.lI3 
Following intraperitoneal dosage, 2-PAM 
iodide reached its maximum effect in rats 
within 30 minutes and had declined to about 
50% of maximum effectiveness at the end 
of the first hour. A further decline in activity 
took place during the second hour, but even 
at the end of 2 hours, some protective effect 
was still evident. Following intravenous 
dosing, 2-PAM iodide appears to be well 
dispersed in all body tissues with the excep-
tion of the brain.88 These same authors found 
that 2-PAM iodide was rapidly excreted in 
man following intravenous dosage. The half-
life was 0.9 hours. Excretion was primarily 
by the kidneys. In nephrectomized dogs and 
rats and in a patient with chronic nephritis 
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and azotemia, excretion was retarded. In 
vitro, 2-PAM iodide was metabolized aero-
bically by rat liver slices. 
P2S is also rapidly excreted in man follow-
ing intravenous dosing.136 Absorption of P2S 
after intramuscular or oral administration 
was not satisfactory. 
DAM is excreted somewhat more slowly 
in man than is 2-PAM iodide.88 The half-life 
for the former compound is 7.2 hours. Rela-
tively little of the DAM could be recovered 
from the urine. Apparently, the liver is of 
major importance in the metabolism of 
DAM.311,88 
Loomis 103 has tried 2-P AM in the treat-
ment of local ocular effects of TEPP and 
sarin in rabbits. He found that 2-PAM 
iodide applied locally was very effective in 
reversing miosis induced by organic phos-
phorus compounds. The reversal was brought 
about by 2-PAM iodide in 2 to 3 hours; 
whereas, if allowed to remit spontaneously, it 
required from 24 to 48 hours or even longer. 
The most effective dosage form was a petro-
latum-based ointment, containing 0.1 % of 
2-PAM iodide. In contrast to Loomis' results, 
Kewitz et al.1l3 reported that local application 
of 2-PAM iodide had no effect on a rabbit's 
pupil constricted by placing diethyl p-nitro-
phenyl phosphate in the eye. However, intra-
venous injection of 50 mg. per kilogram of 
2-PAM iodide brought the pupil back to 
normal size and restored reactivity to light 
within 5 minutes. The formulation in which 
2-PAM iodide was used for local application 
was not stated. It may be that the lack of 
effect was due to use of a water solution of 
2-PAM iodide rather than an oil-based prep-
aration. 
Application of 2-PAM iodide 82,147 and 
MINA 82 relieves the neuromuscular block 
caused by anticholinesterases. Grob and 
Johns 68 reported that DAM reversed the 
local neuromuscular block produced by anti-
cholinesterases in man, but Edery 43 did not 
note this effect in the cat or the rat. In this 
connection, it would be of interest to study 
the effect of these oximes on the paralysis 
caused by certain organophosphorus com-
pounds. Holmes and Robins 82 have stated 
Durham-Hayes 
35 
that the reversal of neuromuscular block is 
due entirely to a reactivation of inhibited 
cholinesterase in the muscle. Wislicki 156 
noted that DAM reduced direct and indirect 
muscular excitability to a marked extent, 
while with 2-PAM iodide these effects were 
slight and were obtained only after intra-
arterial administration. Application of 2-
PAM antagonizes the block caused by the 
competitive type of blocking agent, such as 
curare, and it intensifies the effect of suxame-
thonium. DAM has no definitive influence 
on the former but prolongs the action of the 
latter. Neostigmine, unlike atropine, antago-
nizes the depression of muscle excitability by 
DAM but has no marked effect on the action 
of 2-PAM. 
Longo et al.1°1 have reported that the 
threshold level of sarin necessary to produce 
a "grand mal" electroencephalographic pat-
tern was increased about threefold by 2-PAM 
iodide. However, 2-P AM iodide had no effect 
on the early phase of desynchronization of 
the electroencephalogram. 
Antidotal Efficacy of Oximes in Poisoned 
Experimental Animals 
There are now in the published literature 
numerous reports giving results of the usage 
of 2-PAM salts and other oximes in labora-
tory animals poisoned with various organic 
phosphorus compounds. The compounds 
studied have included demeton,130 DFP,1l3,20, 
78,52 Diazinon,131 dime fox, 131 dimethoate,131 
endothion,54 Ethyl Guthion,130 Guthion,l30 
methyl demeton,54 methyl parathion,131 mor-
phothion,130 paraoxon,1l2.93,17,78 parathion,17, 
155,54,131 phencapton,131 Phosdrin,130 phos-
phamidon,l3o,86.108 Phospholine Iodide,99 sa-
rin,t OMPA,93 tabun, 20.155.52 TEPP,78.155. 
35.52 and phorate.130 Most workers have 
found that the combination of oxime and 
atropine is superior to either antidote used 
alone. However, Sanderson 130 did not note 
any increased benefit of an oxime (2-PAM 
iodide or P2S) plus atropine in comparison 
with atropine alone in rats given oral doses 
of 10 organic phosphorus and carbamate in-
t References 102, 6, 147, 155, 35, 145, and 52. 
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secticides. With oral Guthion, Ethyl Guthion, 
demeton, and morphothion, 2-PAM iodide 
apparently reduced the beneficial effect of 
atropine. This author did note potentiation 
between atropine and oxime in some instances 
when the poison was given intraperitoneally. 
Sanderson and Edson 131 concluded that the 
relative effectiveness of oxime therapy with 
different organic phosphorus insecticides de-
pends on the proportion of reversible cho-
linesterase inhibition present, as predicted on 
the basis of the structure and duration of 
action of the anticholinesterase compound. 
The efficacy of 2-PAM in the treatment of 
poisoning varies from compound to com-
pound, but it has shown some effectiveness 
in the case of all the materials listed above 
with the exception of dimefox, dimethoate, 
and OMPA. In this connection, it is interest-
ing to note that Tammelin and Enander 138 
reported synthesis of an organic phosphorus 
compound (cholinyl methylphosphonofluori-
date) which caused an inhibition of cholin-
esterase that could not be reversed in vitro 
by 2-PAM iodide. 
Woodard 158 has reported results of stud-
ies with 2- PAM iodide in cattle and sheep 
poisoned with organic phosphorus illsecti-
cides. N either atropine nor 2-P AM iodide 
alone was a satisfactory antidote in these 
animals. A combination of 2-PAM iodide 
and atropine gave good results on cattle 
poisoned with parathion or Diazinon, but not 
on cattle poisoned with malathion or on sheep 
poisoned with parathion. 
It appears likely that different oximes have 
some specificity not only for different or-
ganic phosphorus compounds but also for 
different species. 
The effectiveness of oximes as antidotes 
has also been tested in poisoning by certain 
other cholinesterase inhibitors which are not 
organic phosphorus compounds. The use of 
2-P AM iodide has been reported to be in-
effective, if not detrimental, in the treatment 
of poisoning by the carbamate insecticide 
Sevin in rats and dogS.22 ,180 On the other 
hand, poisoning in the rat by the carbamate 
insecticides Isolan and Dimetilan was bene-
fited by 2- PAM iodide.130 It has also been 
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shown that 2-PAM iodide and DAM reverse 
the physiological effects of neostigmine 
(which is a substituted carbamate.) and sev-
eral of its derivatives.68 
Application of 2-PAM in 
Poisoning in Man 
The oxime 2-PAM has now been used in 
the treatment of poisoning in man in a num-
ber of instances. 
Namba and Hiraki 114 have reported a 
series of 5 cases. All of these cases were 
classified by the authors as serious-indicat-
ing a potentially fatal outcome-if untreated. 
However, one of those patients was already 
asymptomatic at the time he received 2-PAM 
iodide. A second patient who had previously 
received 10 mg. of atropine showed no clini-
cal improvement immediately after receiving 
100 mg. of 2-PAM iodide intravenously. He 
did, however, improve about 3 hours later 
(6 hours after onset of symptoms). A third 
case was given ten 100-mg. intravenous doses 
of 2-P AM iodide during a period of 3.5 
hours. By the end of this time, all symptoms 
had disappeared. A fourth patient became 
symptom-free after doses of 500 and 400 
mg. of 2-PAM iodide, separated by 10 min-
utes. The fifth case received 1 gm. of 2-
P AM iodide intravenously, which the authors 
considered to represent the ideal treatment. 
Within 21 minutes, all the symptoms in this 
fifth case, including muscle fasciculations, 
had disappeared. 
In 3 of the 5 cases cited above, the erythro-
cyte cholinesterase level returned to normal 
in 10 minutes, 40 minutes, and 3.5 hours, 
respectively. In the fourth case the recovery 
of the red-cell enzyme was signific;mtly more 
rapid than that of the untreated control. In 
the fifth case, it is not clear from the data 
presented that the red-cell enzyme level was 
ever significantly depressed. No immediate 
effect of 2-PAM iodide on plasma cholin-
esterase was evident, but in all treated cases 
studied, this enzyme returned to a normal 
level more rapidly than did the untreated con-
trol. 
It should be especially noted that the re-
covery in 4 out of 5 of these human cases was 
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after 2-PAM iodide alone. Only 1 of the 
patients received a combination of 2-P AM 
iodide and atropine. The work with experi-
mental animals cited above would lead one 
to expect that a combination of both drugs 
would be more effective than either alone. 
In a later paper, Namba 112 reported the 
results of the use of 2-PAM iodide in an 
additional 26 cases of accidental parathion 
poisoning and in 2 cases of attempted suicide 
by ingestion of parathion. The accidental 
poisonings were treated with 1 to 2 gm. of 
2-PAM iodide intravenously. Marked im-
provement was noted within 30 minutes. 
Pallor was the only symptom remaining in 
5 cases, miosis in 3 cases, and difficulty of 
speech and tachypnea in 2 cases. These re-
maining symptoms had cleared within 1 hour 
after treatment. Complete recovery of con-
sciousness occurred in 5 cases. Symptoms 
such as nausea, headache, dizziness, and 
numbness of extremities did not respond as 
well to 2-PAM as did the others just men-
tioned. Some of these effects persisted for as 
long as 1 week. To be effective in cases of 
ingestion of parathion, it was necessary to 
give very large doses of 2-PAM. Continu-
ous intravenous infusion of 2-PAM at the 
rate of 0.5 gm. per hour is preferred by Dr. 
N amba. One patient received a total dose 
of 40.5 gm. of 2-PAM iodide, recovering 
without apparent ill effect. Namba 112 men-
tioned exploratory study of the use of 2-
PAM for the prophylaxis of parathion 
poisoning. 
Funckes 62 has reported the successful 
treatment with 2-P AM iodide and atropine 
of a severe case of occupational parathion 
poisoning. This patient was given 1 gm. of 
2-P AM iodide intravenously about 1 hour 
after illness began, and he improved dramati-
cally within 10 minutes. Although blood 
cholinesterase levels prior to administration 
of 2-PAM iodide were not determined, the 
enzyme activities after the drug was given 
indicated reactivation of erythrocyte cholin-
esterase (0.32 ~ pH per hour) as measured 
by the method of Miche1 107 and expressed 
in terms of change of pH per hour; there was 
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little or no effect on plasma enzyme (0.04 
~ pH per hour). 
Quinby and Clappison 121 used 2-P AM 
iodide in the treatment of a 2-year-old child 
who ate dirt contaminated with parathion. 
The child was given an intravenous dose of 
250 mg. of 2-PAM iodide following repeated 
doses of atropine. The critically ill, uncon-
scious child returned to an almost normal state 
in less than 20 minutes after the oxime dosage 
was given. The levels of both plasma and 
erythrocyte cholinesterase were near 0 before 
2-PAM, but 20 minutes after its administra-
tion, the erythrocyte cholinesterase level had 
returned to within the range of normal. The 
reactivation of plasma enzyme level was much 
slower, the normal level being reached be-
tween the third and nineteenth days. p-Nitro-
phenol was excreted in the urine quite rapidly, 
clearing in about 30 hours from ingestion. 
Schvartsman and his colleagues 132 treated 
a child who had ingested a commercial solu-
tion of parathion. The treatment included 
milk, atropine, stropanthin, and 300 mg. of 
2-PAM sulfonate. The child regained con-
sciousness and began to improve after treat-
ment; he was discharged from the hospital 
after 3 days. 
Karlog et al.89 have reported the treatment 
with atropine and 2-PAM iodide of a patient 
who attempted suicide by taking an estimated 
1.75 gm. of parathion by mouth. This patient 
was given very large doses of atropine 
beginning soon after poisoning. His respira-
tion ceased, and he was given artificial respi-
ration for 5 hours after poisoning. He was 
not given any 2- PAM until 2.5 days after 
poisoning. During the next 12 hours he was 
given 3.5 gm. of the antidote. Each dose of 
2-P AM iodide produced transitory rises in 
plasma and erythrocyte cholinesterase ac-
tivity which persisted for only a few hours, 
but the patient eventually recovered. 
Rosen 1'25 treated with 2-PAM iodide a 
young man who was poisoned by accidentally 
spilling a gallon bottle of parathion concen-
trate on his hands. This patient was given 
adequate doses of atropine during the first 18 
hours after poisoning, and by the end of this 
time he was symptom-free except for per-
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sisting muscular weakness. After 2-P AM 
was administered, prompt improvement in 
muscle strength was noted. 
One of the most severe poisoning cases 
treated with 2-PAM is that reported by 
Imo.85 A young girl drank parathion with 
suicidal intent. She was found unconscious, 
in convulsions, foaming at the mouth, and 
unreactive even to the strongest stimulus. 
She had almost no pulse and was cy-
anotic and areflectic. Atropine, artificial 
respiration, Stereofundin, and nikethamide 
(Coramine) were given, and spontaneous 
respiration was restored. About 9 hours later, 
500 mg. of 2-PAM iodide was given. Within 
1 hour, the patient regained color, became 
completely conscious, and her pupillary re-
flexes returned to normal. Further recovery 
was uneventful. 
Other instances of parathion poisoning 
treated with 2-PAM include a series of 10 
cases (of which 6 were attempted suicide) 
reported by Erdmann.47 Three of these pa-
tients recovered, 3 died, and in 4 cases the 
outcome is not indicated. 
Erdmann and Latki 48 have used 2-PAM 
iodide in the treatment of a case of poisoning 
from inhalation of DFP. The administration 
of atropine and 2-PAM iodide (2 doses of 
500 mg. each, orally, 2 and 5 hours after ex-
posure) produced prompt remission of 
symptoms with the exception of miosis, which 
persisted for 8 to 10 days and led to a severe 
conjunctivitis. Some increase in erythrocyte 
cholinesterase activity was noted after 2-
PAM, but the enzyme level did not return to 
normal until about 30 days later. 
In 2 cases of moderately severe 2-carbo-
methoxy-l-methyl-vinyldimethyl phosphate 
(Phosdrin) poisoning, Funckes 63 noted a 
less dramatic clinical response to 2-P AM 
iodide than in the case of parathion poisoning. 
Both of the 2-P AM -treated Phosdrin cases 
continued to show symptoms of poisoning for 
several hours after receiving the antidote. 
However, the erythrocyte cholinesterase level 
was significantly increased, and the plasma 
enzyme was regenerated to a lesser degree 
after 2-P AM therapy. 
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A formulating plant worker studied by 
Quinby and Congdon 122 became poisoned 
while working with parathion. He had a very 
low blood cholinesterase level (plasma 0.10 
and erythrocytes 0.08 A pH per hour) during 
his acute illness and was given atropine ther-
apy. His gastrointestinal complaints, par-
ticularly anorexia and nausea, as well as 
weakness, headache, and malaise, persisted. 
He continued to work in the plant, although 
presumably he was removed from direct con-
tact with insecticides. However, his urinary 
p-nitrophenol excretion indicated continued 
exposure to parathion. Because of these con-
tinuing symptoms, and in an attempt to raise 
his blood cholinesterase level sufficiently to 
permit his safe return to his regular work, 
this man was given 1 gm. of 2-PAM chloride 
6 days after his acute illness. The antidote 
had little or no effect on his blood cholinester-
ase level, but he felt much better the next 
mormng. 
It is apparent from brief case reports that 
the use of 2-PAM in combination with 
atropine is considered effective and is routine 
in the treatment of poisoning by organic phos-
phorus insecticides in Israel.2 
Suggestions for Treatment 
The following suggestions are provided as 
a guide to the physician who may be called 
upon to treat persons poisoned by anti-
cholinesterase compounds: 
I. In very severe cases, the order of treatment 
should be as follows: 
(1) ARTIFICIAL RESPIRATION, pref-
erably by mechanical means. 
(2) ATROPINE, 2 to 4 mg. (1/30 to 1/15 
grain) intravenously as soon as cyanosis 
is overcome. Repeat at 5- to lO-minute in-
tervals until signs of atropinization ap-
pear (dry, flushed skin and tachycardia 
as high as 140 per minute). 
(3) 2-PAM, 1 gm. slowly, intravenously. 
(4) DECONTAMINATION of the skin, 
stomach, and eyes as indicated. 
(5) SYMPTOMATIC TREATMENT. 
II. In the more usual case, proceed as follows: 
(1) ATROPINE, 1 to 2 mg. (1/60 to 1/30 
grain), if symptoms appear. If excessive 
secretions occur, keep the patient fully 
atropinized. Give atropine sulfate every 
hour up to 25 to 50 mg. in a day. 
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(2) DECONTAMINATION of the skin, 
stomach, and eyes as indicated. 
(3) 2-PAM, 1 gm. slowly, intravenously if 
the patient fails to respond satisfactorily 
to atropine. 
(4) SYMPTOMATIC TREATMENT. 
It will be noted that this recommended 
dosage of atropine is greater than that con-
ventionally employed for other purposes but 
is within safe limits. People poisoned by 
anticholinesterase organic phosphorus com-
pounds have an increased tolerance for atro-
pine. For additional discussion of atropine 
usage, see "Use of Atropine and Other Non-
specific Antidotes," above. 
Although different oximes offer somewhat 
different therapeutic possibilities, 2-PAM ap-
pears to be the most generally useful oxime 
now available. There appears to be no es-
sential difference in the effects of the differ-
ent salts of 2-PAM, and 2-PAM chloride 
does have the advantage of greater solubility 
and lack of iodine taste as compared to 2-
PAM iodide, which used to be more easily 
available. A dosage of 10 to 20 mg. per kilo-
gram has proved a safe but generally effective 
level. As a round figure, 1 gm. should be an 
average adult dose. Intravenous administra-
tion is recommended to obtain rapidity of 
action. Since 2-PAM is excreted rapidly, 
repeated doses may be necessary, particularly 
in cases involving parathion or other com-
pounds that must undergo bioactivation be-
fore becoming toxic. It is important to note, 
however, that the only known signs or symp-
toms of overdosage with 2-PAM are identical 
to the manifestations of poisoning with anti-
cholinesterases. 2-PAM should be adminis-
tered in conjunction with adequate doses of 
atropine. Other supportive treatment, includ-
ing particularly artificial respiration, should 
also be carried out as required. 
The value of 2-PAM is most thoroughly 
established in connection with the treatment 
of poisoning by parathion. When used in 
cases of poisoning by other organic phos-
phorus insecticides, it should be with the 
awareness that it may be somewhat less ef-
fective. In fact, 2-PAM appears to be in-
effective in treating poisoning due to OMPA. 
Durham-Hayes 
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Until 2-PAM is freely available for pre-
scription it is recommended that the limited 
supply not be drawn upon in cases of mild 
poisoning or in cases that show a completely 
satisfactory response to atropine. 
Consideration should be given to local ap-
plication of 2-PAM to the skin to reduce 
dermal absorption in exposed persons, and 
to the eyes to reverse organic-phosphorus-in.-
duced miosis. The use of 2-PAM for the 
prevention rather than the treatment of sys-
temic poisoning has been proposed. These 
procedures seem to be safe on the basis of 
limited studies with experimental animals, 
although their effectiveness has not been 
proved. These procedures are strictly ex-
ploratory, while the value of 2-PAM for 
treatment of systemic poisoning, especially 
by parathion, is established. 
N ever give morphine, theophylline, or 
theophylline-ethylene-diamine (aminophyl-
line) to a patient poisoned with an anticholin-
esterase agent. Do not give atropine to a 
cyanotic patient; give artificial respiration 
first, and then give atropine. Large amounts 
of intravenous fluids are generally contra-
indicated because of excessive fluid in the 
respiratory tract. Tranquilizers should be 
used with great caution; they are seldom 
indicated at all. Succinyl choline should not 
be given. 
If pulmonary secretions have accumulated 
before atropine has become effective they 
should be removed by suction and a catheter. 
If the stomach is distended, empty it with a 
Levine tube. 
If the patient has not yet shown symptoms 
or they have been allayed by treatment, he 
must be completely and quickly decontami-
nated. Remove the patient's clothing and, 
with due regard for his condition at the 
moment, bathe him thoroughly. Remove any 
visible insecticide gently with a generous 
amount of soap and water or other detergent 
if available. Avoid abrasion. When the skin 
appears clear, bathe or swab with ethyl al-
cohol. Parathion and many of the other or-
ganic phosphorus insecticides are very much 
more soluble in alcohol than in water, and 
significant amounts can be washed from skin 
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that has been scrubbed several times with 
soap and water. 
I f there is any suspicion that the poison 
has been ingested or inhaled and if the patient 
is still responsive, induce vomiting, give some 
neutral material such as milk or water, and 
induce vomiting again. The reason for men-
tioning inhaled material is, of course, that a 
large portion of it is deposited in the upper 
respiratory tract and subsequently carried to 
the pharynx and swallowed. Nausea may be 
anticipated on the basis of the systemic action 
of these compounds, but if vomiting is not 
profuse, gastric lavage may be used. Experi-
ments have indicated that vomiting induced 
immediately or even 1.5 hr. after ingestion is 
more effective than gastric lavage in removing 
pOlson. 
It must be kept in mind hOW little parathion 
is necessary to produce poisoning by the oral 
route. Repeated dosage at the rate of 7.2 
mg. per man per day led to moderate reduc-
tion of blood cholinesterase activity.44a A 
dose of 25 to 50 mg. was fatal to a child,132a 
and a dose of 120 mg. was fatal to an adult.17a 
Atropine does not protect against muscu-
lar weakness. The usual mechanism of death 
appears to be respiratory failure. The use 
of an oxygen tent or even the use of oxygen 
under slight positive pressure is advisable 
and should be started early. Watch the patient 
constantly, since the need of artificial respira-
tion may appear suddenly. Equipment for 
oxygen therapy and for artificial respiration 
should be placed at the patient's bedside in 
readiness while the patient is on his way to 
the hospital. Cyanosis should be prevented 
by the most suitable means, since continued 
anoxia aggravates the depression of the 
respiratory center caused by the poison direct-
ly. Complete recovery may occur even after 
many hours of artificial respiration have been 
necessary. 
If there is any reason to think that the 
eyes may have been contaminated, irrigate 
them with isotonic saline solution or water. 
The absorption of some of the organic phos-
phorus insecticides by the eye is remarkably 
rapid. 
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The acute emergency lasts 24 to 48 hours, 
and the patient must be watched continuously 
during that time. Favorable response to one 
or more doses of atropine does not guarantee 
against sudden and fatal relapse. Medication 
must be continued during the entire emer-
gency. Any person who is ill enough to re-
ceive a single dose of atropine should remain 
under medical observation for 24 hours, be-
cause the atropine may produce only a tempo-
rary relief of symptoms in what may prove 
to be a serious case of poisoning. Atropine 
should never be administered for preventive 
purposes to persons who have not become 
sick. 
Miosis and headache may persist after re-
covery from poisoning by organic phosphorus 
insecticides is otherwise largely complete. In 
some cases, the systemic administration of 
atropine is followed by partial or temporary 
dilatation of the pupils. Miosis responds 
more dependably to 2-PAM. If further 
systemic treatment is not necessary, the mio-
sis and associated headache will respond to 
the instillation of 0.5% to 1 % atropine solu-
tion or 0.5% atropine ointment into the eyes. 
Following exposure heavy enough to pro-
duce symptoms, further organic phosphorus 
insecticide exposure of any sort should be 
avoided. The patient may remain susceptible 
to relatively small exposures to the same or 
any other organic phosphorus compound 
until regeneration of cholinesterase is nearly 
complete. 
Prevention of Poisoning 
The most important single factor in the 
prevention of poisoning is a knowledge of 
the hazards involved in handling the various 
anticholinesterase compounds. It is essential 
that the facts about the toxicity of these ma-
terials be learned through research and then 
that these facts be made known to all con-
cerned, including the formulating plant 
worker, the commercial sprayman, the 
farmer, the householder (who may purchase 
these insecticides for use in his house or 
garden and, if not adequately warned, may 
leave the toxic materials accessible to children 
or other irresponsible persons), and the 
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physician who may be called upon to treat 
pOlson mg. 
In persons occupationally exposed, poison-
ing can best be prevented by constant, 
thoughtful care and by use, where indicated, 
of safety devices such as protective clothing, 
respirators, masks, air-conditioned cabs, or 
special factory ventilation. 
Prevention can also be approached by ob-
serving trends in serial blood cholinesterase 
determinations on persons constantly ex-
posed. The interpretation of individual 
values in asymptomatic persons is difficult. 
It is clear, however, that a single very low 
enzyme value for one worker or a low 
average value for a group of exposed work-
ers is an indication of the need for improved 
personal care or better mechanical protection 
or both. In a similar way, prevention of 
poisoning may be helped by proper evalua-
tion of the amount of urinary excretion of 
biotransformation products. 
Direct methods are also available to meas-
ure the exposure which spray operators have 
to pesticides during their usual conditions of 
work.42 
Severe poisoning may at times be pre-
vented by the immediate recognition and cor-
rection of contamination. Prompt, effective 
medical treatment may prevent a mild poison-
ing case from developing into a serious one. 
Comment and Summary 
Poisoning due to organic phosphorus com-
pounds may be encountered in relation to 
their use as insecticides; as chemical warfare 
agents; or as drugs for the treatment of ab-
dominal distention, glaucoma, or myasthenia 
gravis. The principal, if not the only, phar-
macologic action of the organic phosphorus 
insecticides is inhibition of the enzyme 
cholinesterase. The inactivity of this enzyme 
results in an accumulation of unhydrolyzed 
acetylcholine and the appearance of signs and 
symptoms referable to overstimulation of the 
parasympathetic nervous system. The drug 
of choice in the treatment of organophos-
phorus poisoning has been atropine. Atropine 
therapy produces relief of certain symptoms 
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based on blocking the action of excess acetyl-
choline, but it has no effect on the basic 
biochemical pathology involved in anticholin-
esterase poisoning. With regard to symptoms, 
atropine is effective in treating those effects 
referable to the central and muscarinic action 
of acetylcholine but has no effect on the nico-
tinic action. 
More recently a series of antidotes has been 
developed that are able to reverse the com-
bination between the cholinf'sterase molecule 
and the inhibitor. These compounds are 
oximes and include salts of, for example, 2-
PAM (2-pyridine aldoxime methiodide) , 
DAM (diacetylmonoxime), MINA (mono-
isonitrosoacetone) and TMB-4 (I,l'-trimeth-
ylene bis ( 4-formyl-pyridinium bromide) 
dioxime) . Since the oximes and atropine 
have different sites of action in the mam-
malian body, it is preferable to use these 2 
agents in combination and thus take advan-
tage of the antidotal effects at both points. 
The most widely used of the oximes in 
treating poisoning is 2-PAM. This com-
pound has at least 3 actions that may be of 
importance in the treatment of poisoning by 
an organic phosphorus compound. These 
actions are: ( I) reactivation of inhibited 
cholinesterase, (2) reaction with and inac-
tivation of the organic phosphorus molecule, 
and (3) inhibition of cholinesterase. Atro-
pine has none of these actions. The dominant 
effect of therapeutic doses of 2-P AM in 
poisoned animals is reactivation of inhibited 
cholinesterase. Application of 2-P AM re-
activates inhibited cholinesterase both in vitro 
and in vivo, except that it has little or no 
effect on the enzyme in the brain. The non-
quaternary oximes ( such as DAM and 
MINA) are able to penetrate the blood-brain 
barrier. With any given inhibitor and re-
activator, the extent of reactivation of cholin-
esterase activity depends upon how long the 
inhibitor and enzyme have been in contact. 
Although the value of 2- PAM in the treat-
ment of organic phosphorus poisoning was 
discovered in the United States and proce-
dures for its use were developed here, and 
although this antidote is now widely available 
for use by physicians in a number of other 
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countries (England, Israel, Japan, and New 
Zealand), it can be purchased in this country 
only by qualified physicians for clinical in-
vestigational use. It is unfortunate that no 
firm has seen fit to market 2-PAM com-
mercially for prescription use in the United 
States. 
Wayland J. Hayes, Jr., Chief, Toxicology Section, 
Public Health Service, Communicable Disease Cen-
ter, Atlanta 22. 
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HEALTH HAZARDS OF PESTICIDES 
The pesticide-related problem t~at the average physician is most likely to face and about 
which he must take immediate and definitive action 
is acute poisoning due to occupational or accidental 
exposure or to suicidal ingestion. 
Almost every pesticide can cause poisoning if it 
is swallowed. For many years and at least as late 
as 1959, the arsenicals caused more accidental 
deaths than any other group of pesticides. This is 
almost certainly due to the casualness with which 
they are still stored and the ease with which they 
can be found and ingested by children and other 
uninformed people. The arsenical pesticides have 
never been an important source of occupational 
disease. Among the newer pesticides, greatest at-
tention has focused on the chlorinated hydrocarbon 
and the organic phosphorus insecticides. Although 
the chlorinated hydrocarbons have caused a mod-
erate number of cases of accidental posioning, their 
record of occupational safety is generally good. In 
fact, the great amount of study they continue to 
receive is justified almost exclusively by their per-
sistence as residues on treated crops and their rela-
tively prolonged storage in the tissues of domestic 
animals and man. However, careful regulation has 
p.revented the residues from offering anything but a 
potential problem. There is no confirmed record of 
clinical effect from eating food treated with pesti-
cides according to approved agricultural practice. 
From the standpoint of occupational hazard, the 
more toxic organic phosphorus insecticides are the 
outstanding offenders among the newer agricultural 
chemicals. This is true in spite of the strict regula-
tion imposed on them from the beginning. This 
regulation and the extensive educational campaign 
that has accompanied their introduction and use 
undoubtedly have restricted both occupational and 
accidental poisoning by these compounds. Granted 
that all noncriminal poisoning can be traced to 
"carelessness," the growing importance of the more 
toxic organic phosphorus insecticides as reported 
causes of occupational disease 1 is almost certainly 
due to the tremendous increase in their use, to their 
inherent toxicity, and to the ease with which many 
of them are absorbed through the skin. 
Two factors specifically favor success in the treat-
ment of poisoning with the organic phosphorus 
compounds, i.e., the short duration of the emer-
gency and the existence of effective antidotes. The 
acute episode lasts only from 24 to 48 hours. Most 
deaths occur within the first 24 hours, and if a pa-
tient survives this long, he usually recovers com-
pletely. 
The principal pharmacologic action of the or-
ganic phosphorus insecticides, if not the only one, is 
inhibition of the enzyme cholinesterase. This results 
in an accumulation of unhydrolyzed acetylcholine 
and. therefore, in signs and symptoms referrable to 
over-stimulation of the parasympathetic nervous 
system. The drug of choice in the treatment of or-
ganophosphorus poisoning has been atropine, 
which relieves certain symptoms by pharmacologiC 
blocking of the action of acetylcholine. Atropine, 
however, has no effect on the basic, biochemical 
pathology involved in anticholinesterase poisoning. 
Furthermore, it has no effect on the nicotinic action 
of acetylcholine although it is effective in treating 
those symptoms referrable to the central and mus-
carinic actions of this neurohumor. 
More recently a series of antidotes has been de-
veloped that can reverse the combination between 
the cholinesterase molecule and the inhibitor. 
These compounds are oximes. The outstanding 
members of this group are the salts of 2-pyridine 
aldoxime, including the methiodide (2-PAM io-
dide ), the methochloride (2-PAM chloride), and 
the ethanesulfonate (P2S). 2-PAM chloride is sold 
in the United States by the Campbell Pharmaceuti-
cal Company, Inc., 121 East 24th St., New York 
City; under the trade name Protopam. This drug is 
marketed under a limited license for sale to quali-
fied physicians for clinical investigations only. 
Emergency supplies are available at some poison-
control centers, at many medical schools, or from 
the U.S. Public Health Service laboratories in At-
lanta, Ga., Wenatchee, Wash., and Phoenix, Ariz. 
In the July issue of the At-chives of Environ-
mental Health (p. 21) there is a review by Wil-
liam F. Durham and Wayland J. Hayes, Jr., on the 
therapy of organic phosphorus poisoning. Special 
attention is given in this review to compounds that 
reactivate inhibited choliJ;lesterase and to their 
proper clinical use in combination with atropine. 
Extensive animal research on salts of 2-pyridine 
aldoxime has been completed. Well-documented, 
clinical use of these compounds in more than 40 
cases of parathion poisoning has established their 
effectiveness and safety for this purpose. More lim-
ited experience indicates their value in the treat-
ment of poisoning by some other organic phos-
phorus compounds. 
Detailed information on the clinical use of these 
drugs is now available to physicians through the 
above-mentioned review. For maximum usage to 
be made of the considerable knowledge now avail-
able on treatment of anticholinesterase poisoning, it 
is necessary that one of these oxime salts be made 
generally available for prescription by physicians in 
the United States. 
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